EP Life Sciences Ltd. — Form D/A

EP Life Sciences Ltd. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2024-03-26. $46.1M was reported sold. Industry: Pooled Investment Fund.

Offering

Issuer

Officers, directors & promoters (16)

NameRoleLocation
Steven W DavdsonDirectorNEW YORK, NY
Gregory W LinkDirectorGrand Cayman, E9
Ralph W WoodfordDirectorGrand Cayman, E9
Ralph WoodfordRelated PersonGrand Cayman, E9
Gregory LinkRelated PersonGeorge Town, Grand Cayman, E9
Patrick JC ShawDirectorNew York, NY
Marty PiccinichRelated PersonNew York, NY
Michael FierroRelated PersonNew York, NY
Michael S FierroDirectorNew York, NY
Gregory S LinkDirectorGrand Cayman, E9
Ralph S WoodfordDirectorGrand Cayman, E9
Kabir S KapoorDirectorNEW YORK, NY
Kabir S KapoorRelated PersonNEW YORK, NY
Marty S PiccinichDirectorNEW YORK, NY
Kurt JC DudasDirectorNew York, NY
Kurt S DudasDirectorNEW YORK, NY

Other filings by this issuer (8)

FiledFormOfferingSold
2026-03-16D/A$52.8M
2025-03-21D/A$46.3M
2023-03-27D/A$46.9M
2022-03-28D/A$48.5M
2021-06-08D/A$44.6M
2020-06-08D/A$31.3M
2019-06-17D/A$29.1M
2018-06-28D

More